Reduced Enterohepatic Recirculation of Mycophenolate and Lower Blood Concentrations are Associated with the Stool Bacterial Microbiome After Hematopoietic Cell Transplantation.
暂无分享,去创建一个
A. Khoruts | C. Staley | M. MacMillan | A. Rashidi | T. Kaiser | P. Jacobson | Jo-Anne H. Young | M. Al-Kofahi | D. Weisdorf | S. Holtan | N. Jurdi | A. Saqr | Brooke Carlson | B. Carlson
[1] Ana Rita Brochado,et al. Bioaccumulation of therapeutic drugs by human gut bacteria , 2021, Nature.
[2] T. van Gelder. How cyclosporin reduces mycophenolic acid exposure by 40% while other calcineurin inhibitors do not. , 2021, Kidney international.
[3] Michael R. Taylor,et al. Gut microbiota profiles and fecal beta‐glucuronidase activity in kidney transplant recipients with and without post‐transplant diarrhea , 2021, Clinical transplantation.
[4] T. Kuwahara,et al. Parabacteroides distasonis: intriguing aerotolerant gut anaerobe with emerging antimicrobial resistance and pathogenic and probiotic roles in human health , 2021, Gut microbes.
[5] R. Paredes,et al. Associations of the gut microbiome and clinical factors with acute GVHD in allogeneic HSCT recipients. , 2020, Blood advances.
[6] Bahar Javdan,et al. Personalized Mapping of Drug Metabolism by the Human Gut Microbiome , 2020, Cell.
[7] J. Kanda,et al. Drug monitoring for mycophenolic acid in graft‐vs‐host disease prophylaxis in cord blood transplantation , 2020, British journal of clinical pharmacology.
[8] S. Paczesny,et al. Biomarkers for Allogeneic HCT Outcomes , 2020, Frontiers in Immunology.
[9] A. Koh,et al. The gut microbiota in transplant patients. , 2020, Blood reviews.
[10] A. Khoruts,et al. Levaquin gets a pass. , 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[11] Patrick D Schloss,et al. Reintroducing mothur: 10 Years Later , 2019, Applied and Environmental Microbiology.
[12] A. Goodman,et al. Insights from pharmacokinetic models of host-microbiome drug metabolism , 2019, Gut microbes.
[13] Michael R. Taylor,et al. Vancomycin relieves mycophenolate mofetil–induced gastrointestinal toxicity by eliminating gut bacterial β-glucuronidase activity , 2019, Science Advances.
[14] A. Goodman,et al. Mapping human microbiome drug metabolism by gut bacteria and their genes , 2019, Nature.
[15] D. Fredricks. The gut microbiota and graft-versus-host disease. , 2019, The Journal of clinical investigation.
[16] Rohit Loomba,et al. Microbiome 101: Studying, Analyzing, and Interpreting Gut Microbiome Data for Clinicians , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[17] Matthew R. Redinbo,et al. Three structurally and functionally distinct β-glucuronidases from the human gut microbe Bacteroides uniformis , 2018, The Journal of Biological Chemistry.
[18] Luke R. Thompson,et al. Best practices for analysing microbiomes , 2018, Nature Reviews Microbiology.
[19] Peer Bork,et al. Extensive impact of non-antibiotic drugs on human gut bacteria , 2018, Nature.
[20] M. Brink,et al. Gut microbiota injury in allogeneic haematopoietic stem cell transplantation , 2018, Nature Reviews Cancer.
[21] M. Redinbo,et al. An Atlas of β-Glucuronidases in the Human Intestinal Microbiome. , 2017, Structure.
[22] Xiaowei Zhan,et al. Antibiotic-Induced Depletion of Anti-inflammatory Clostridia Is Associated with the Development of Graft-versus-Host Disease in Pediatric Stem Cell Transplantation Patients. , 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[23] J. McCune,et al. Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics of Immunosuppressants in Allogeneic Hematopoietic Cell Transplantation: Part II , 2016, Clinical Pharmacokinetics.
[24] Y. Taur,et al. Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host Disease. , 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[25] M. Perales,et al. Intensified Mycophenolate Mofetil Dosing and Higher Mycophenolic Acid Trough Levels Reduce Severe Acute Graft-versus-Host Disease after Double-Unit Cord Blood Transplantation. , 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[26] S. Rampelli,et al. Gut microbiota trajectory in pediatric patients undergoing hematopoietic SCT , 2015, Bone Marrow Transplantation.
[27] N. Kadowaki,et al. Monitoring mycophenolate mofetil is necessary for the effective prophylaxis of acute GVHD after cord blood transplantation , 2015, Bone Marrow Transplantation.
[28] C. Staatz,et al. Pharmacology and toxicology of mycophenolate in organ transplant recipients: an update , 2014, Archives of Toxicology.
[29] Daniel Wolff,et al. Metagenomic analysis of the stool microbiome in patients receiving allogeneic stem cell transplantation: loss of diversity is associated with use of systemic antibiotics and more pronounced in gastrointestinal graft-versus-host disease. , 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[30] B. Sandmaier,et al. Nonrelapse mortality and mycophenolic acid exposure in nonmyeloablative hematopoietic cell transplantation. , 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[31] T. Shokati,et al. A high-throughput U-HPLC-MS/MS assay for the quantification of mycophenolic acid and its major metabolites mycophenolic acid glucuronide and mycophenolic acid acyl-glucuronide in human plasma and urine. , 2012, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[32] Baris E. Suzek,et al. The Universal Protein Resource (UniProt) in 2010 , 2009, Nucleic Acids Res..
[33] E. Deconinck,et al. Pharmacokinetics of mycophenolic acid administered 3 times daily after hematopoietic stem cell transplantation with reduced-intensity regimen. , 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[34] J. Wagner,et al. Comparison of two mycophenolate mofetil dosing regimens after hematopoietic cell transplantation , 2009, Bone Marrow Transplantation.
[35] S. Duncan,et al. Distribution of beta-glucosidase and beta-glucuronidase activity and of beta-glucuronidase gene gus in human colonic bacteria. , 2008, FEMS microbiology ecology.
[36] R. Borrows,et al. The Magnitude and Time Course of Changes in Mycophenolic Acid 12-Hour Predose Levels During Antibiotic Therapy in Mycophenolate Mofetil-Based Renal Transplantation , 2007, Therapeutic drug monitoring.
[37] Peter D. Karp,et al. MetaCyc: a multiorganism database of metabolic pathways and enzymes , 2005, Nucleic Acids Res..
[38] D. Weisdorf,et al. Relationship of mycophenolic acid exposure to clinical outcome after hematopoietic cell transplantation , 2005, Clinical pharmacology and therapeutics.
[39] R. Borrows,et al. Determinants of Mycophenolic Acid Levels After Renal Transplantation , 2005, Therapeutic drug monitoring.
[40] E. Heinzen,et al. The Influence of Norfloxacin and Metronidazole on the Disposition of Mycophenolate Mofetil , 2005, Journal of clinical pharmacology.
[41] Y. Benno,et al. Comparison of Four Microbial Enzymes in Clostridia and Bacteroides Isolated from Human Feces , 2002, Microbiology and immunology.
[42] M. Hale,et al. Pharmacokinetics of mycophenolate mofetil (RS61443): a short review. , 1996, Transplantation proceedings.
[43] J. Hasselström,et al. Morphine Pharmacokinetics and Metabolism in Humans , 1993, Clinical pharmacokinetics.
[44] K. R. Clarke,et al. Non‐parametric multivariate analyses of changes in community structure , 1993 .
[45] J. McCune,et al. Pharmacokinetics, Pharmacodynamics and Pharmacogenomics of Immunosuppressants in Allogeneic Haematopoietic Cell Transplantation: Part I , 2015, Clinical Pharmacokinetics.
[46] C. Staatz,et al. Clinical Pharmacokinetics and Pharmacodynamics of Mycophenolate in Solid Organ Transplant Recipients , 2007, Clinical pharmacokinetics.
[47] V. Armstrong,et al. Validation of a rapid and sensitive liquid chromatography-tandem mass spectrometry method for free and total mycophenolic acid. , 2004, Clinical chemistry.
[48] J. L. Martindale. Subtle enablers. , 1984, The Journal of the Arkansas Medical Society.